Skip to main content
. 2011 Nov 29;34(3):738–752. doi: 10.1002/hbm.21471

Table II.

Composition of samples in each individual study and of the actual overall sample

First author Menstrual cycle phase Average age Manual dominance Partecipants
Bingel, 2006 12 4 Unknown 24 Right Healthy
Craggs, 2008; Price, 2007 0 9 Unknown or PMPa 27.7 Unknown IBSb
Eippert, 2009a 19 0 26.1 Unknown Healthy
Kong, 2006 9 7 Unknown 28.4 Right Healthy
Lu, 2010 5 9 Mid‐Proliferative 23.9 Right FGIDc
Lui, 2010 13 18 Unknown 23.5 Right (26), left (1) Healthy
Nemoto, 2007 Unknown Unknown 23 Right Healthy
Petrovic, 2002 9 0 Range 20–70 Unknown Healthy
Wager [S1], 2004 Unknown Unknown Unknown Healthy
Wager [S2], 2004 Unknown Unknown Right Healthy
Watson, 2009 5 6 27.5 Right Healthy
Subjects (N) Gender Menstrual cycle phase (N) Average age Manual dominance (N) Health status (N)
199 ♂ (72) MPPd (9) 28.18 (± 7.93) Right (148); Left (1) Healthy subjects (172)
♀ (62) PMP (9) Left‐Right (4) FGID (9)
Unknown (65) Unknown (44) Unknown (46) IBS (18)
a

Premenopausal phase.

b

Irritable bowel syndrome.

c

Functional gastrointestinal disorders.

d

Mid‐Proliferative Phase. Only the works by Lui [2010], Nemoto [2007], and Wager [2004] indicated the placebo responders: 12, 5, and 36, respectively. The placebo conditioning have been investigated only in two of the considered studies [Watson et al., 2009; Lui et al., 2010].